Why you should read this article:

•

To enhance your knowledge of the use of sodium glucose co-transporter 2 (SGLT2) inhibitors in the management of type 2 diabetes

•

To be aware of the benefits and side effects of SGLT2 inhibitors

•

To understand the role of nurses in ensuring that SGLT2 inhibitors are used safely and appropriately

One class of oral medicines used in the management of type 2 diabetes is sodium glucose co-transporter 2 (SGLT2) inhibitors. Their mode of action is unique and is not dependent on beta-cell function or the degree of a person’s insulin resistance. This article reviews the use of SGLT2 inhibitors in managing type 2 diabetes, explaining the potential benefits and side effects of these medicines. It also explains the role of healthcare professionals, including nurses, in ensuring these medicines are used safely and appropriately.